IONIS PHARMACEUTICALS INC
For the period ended Mar 31, 2025. Filed Apr 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed Apr 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
| ITEM 5. | OTHER INFORMATION |
|---|
Trading Plans
During the quarter ended March 31, 2025, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act), or Section 16 officers and directors, did notadopt orterminate contracts, instructions or written plans for the purchase or sale of our securities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.